远大医药TLX591-CDx国内III期临床给药完成 计划今年内递交新药上市申请

中国网财经
12 May

中国网财经5月12日讯 今日,远大医药(0512.HK)股价延续上周涨势,并一举创下了8.95港元的历史高点,盘中大涨20%,市值突破300亿港元,收报8.32港元,较年内低点上涨超110%。当日晚间,远大医药公布又一创新核药研发进展,公司用于诊断前列腺癌的全球创新在研放射性核素偶联药物(RDC) TLX591-CDx (Illuccix®, gallium Ga 68 PSMA-11)中国III...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10